PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS
本页收录老挝专利「PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS」的公开登记要点，由 NICOX OPHTHALMICS, INC. 于 2020-07-21 提交申请，当前状态为等待形式审查。关键编号与类型标注为 申请号 P/825 / DIP 编号 LAP825 / 主管局代码 LA / 保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-02-27。国际分类 / IPC 标注为 A61K 31/573、A61K 47/02、A61K 47/10、A61K 9/10、A61K 9/14、A61P 27/00、C07J 31/00、C07J 71/00。发明人 / 设计人包括 BOYER, José L.、BUKOWSKI, Jean-Michel、DUQUESROIX-CHAKROUN, Brigitte、NADKARNI, Akshay、NAVRATIL, Tomas。代理机构 / 代理人记载为 Tilleke & Gibbins Lao Co.,Ltd。公开摘要提示：The present invention relates to an improved process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of…。
This Laos Patent “PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS” is a public DIP intellectual-property record, filed by NICOX OPHTHALMICS, INC. on 2020-07-21; current status: Awaiting formal examination. Identifiers include application No. P/825; DIP id LAP825; protection kind Patent - PCT National Phase. Key dates: publication 2026-02-27. Classification: A61K 31/573、A61K 47/02、A61K 47/10、A61K 9/10、A61K 9/14、A61P 27/00、C07J 31/00、C07J 71/00. Inventor(s)/designer(s): BOYER, José L., BUKOWSKI, Jean-Michel, DUQUESROIX-CHAKROUN, Brigitte, NADKARNI, Akshay, NAVRATIL, Tomas. Abstract hint: The present invention relates to an improved process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
ສິດທິບັດ «PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS» ເປັນຂໍ້ມູນຊັບສິນທາງປັນຍາເປີດເຜີຍຂອງ DIP, ຍື່ນໂດຍ NICOX OPHTHALMICS, INC. ໃນວັນທີ 2020-07-21; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/825; ລະຫັດ DIP LAP825; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-02-27. ປະເພດ/ຫ້ອງ: A61K 31/573、A61K 47/02、A61K 47/10、A61K 9/10、A61K 9/14、A61P 27/00、C07J 31/00、C07J 71/00. ນັກປະດິດ/ນັກອອກແບບ: BOYER, José L., BUKOWSKI, Jean-Michel, DUQUESROIX-CHAKROUN, Brigitte, NADKARNI, Akshay, NAVRATIL, Tomas. ສະຫຼຸບ: The present invention relates to an improved process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of…. ຂໍ້ມູນເພື່ອອ້າງອີງເທົ່ານັ້ນ ບໍ່ແມ່ນຄຳແນະນຳທາງກົດໝາຍ ຫຼື ໃບຢັ້ງຢືນສິດ.
P/825
图样
基础信息
- 类型
- 专利
- 申请号
P/825- 状态
- 等待形式审查
- 申请人
- NICOX OPHTHALMICS, INC.
- 代理机构
- Tilleke & Gibbins Lao Co.,Ltd
- 申请日期
- 2020-07-21
- 公开/公告日
- 2026-02-27
- 国际分类
- A61K 31/573 · A61K 47/02 · A61K 47/10 · A61K 9/10 · A61K 9/14 · A61P 27/00 · C07J 31/00 · C07J 71/00
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
The present invention relates to an improved process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of fluticasone propionate Form A. The sterile topical ophthalmic nanosuspensions are useful in the treatment of eye inflammation conditions such as blepharitis, posterior blepharitis, Meibomian gland dysfunction and dry eye through topical administration of said nanosuspensions to eyelids, eyelashes and eyelid margin.
The present invention relates to an improved process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of fluticasone propionate Form A. The sterile topical ophthalmic nanosuspensions are useful in the treatment of eye inflammation conditions such as blepharitis, posterior blepharitis, Meibomian gland dysfunction and dry eye through topical administration of said nanosuspensions to eyelids, eyelashes and eyelid margin.